Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003082 | Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 27 | University of ArizonaOTHER | 1 | Mar 16, 2010 | clinicaltrials |
| NCT00084513 | Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer | completed | Phase 1 | 18 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00025454 |
| R115777 in Treating Patients With Advanced Solid Tumors |
| completed |
| Phase 1 |
| — |
| City of Hope Medical CenterOTHER |
| 1 |
| Feb 8, 2010 |
| clinicaltrials |
| NCT00990912 | A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002) | completed | Phase 1 / Phase 2 | 20 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 5, 2010 | clinicaltrials |
| NCT00091325 | Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of ArizonaOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00006464 | UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004220 | Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00004243 | Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00006257 | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00249977 | Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan | completed | Phase 1 | 21 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00005077 | Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00006485 | Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00544063 | Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer | unknown | Phase 1 | 33 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00004877 | BMS-214662 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 3, 2009 | clinicaltrials |
| NCT00487058 | A Phase I Dose Escalation Study of LBQ707 (Gimatecan) Administered Orally Twice Per Week to Japanese Patients With Advanced Solid Tumors | completed | Phase 1 | 28 | NovartisINDUSTRY | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00520637 | A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01) | completed | Phase 1 | 34 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 9, 2009 | clinicaltrials |
| NCT00710697 | Cardiac Safety Assessment Study of Picoplatin in Solid Tumors | unknown | Phase 1 | 40 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00509613 | Phase 1 Study With Sorafenib and Sirolimus | completed | Phase 1 | — | Radboud University Medical CenterOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00004923 | Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 47 | Yale UniversityOTHER | 1 | Aug 25, 2009 | clinicaltrials |
| NCT00037804 | Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Aug 14, 2009 | clinicaltrials |
| NCT00955292 | Dose-escalation Study of Quarfloxin in Patients With Advanced Solid Tumors or Lymphomas | terminated | Phase 1 | 12 | Cylene PharmaceuticalsINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00955786 | Dose-escalation Study of CX-3543 in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 48 | Cylene PharmaceuticalsINDUSTRY | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00091806 | Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors | completed | Phase 1 | 86 | AmgenINDUSTRY | 0 | Jul 10, 2009 | clinicaltrials |
| NCT00497731 | AZD1152 in Patients With Advanced Solid Malignancies-Study 1 | terminated | Phase 1 | 70 | AstraZenecaINDUSTRY | 1 | Jun 22, 2009 | clinicaltrials |
| NCT00503477 | A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00497679 | AZD1152 in Patients With Advanced Solid Malignancies-Study 3 | terminated | Phase 1 | 45 | AstraZenecaINDUSTRY | 1 | May 14, 2009 | clinicaltrials |
| NCT00004063 | Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer | unknown | Phase 1 / Phase 2 | 30 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 30, 2009 | clinicaltrials |
| NCT00881101 | Clinical Study of Liposomal Paclitaxel in Chinese Patients | unknown | Phase 1 | 15 | Nanjing Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00881244 | Study of AS1411 in Advanced Solid Tumours | completed | Phase 1 | 30 | Antisoma ResearchINDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00863733 | Study of DMXAA (Now Known as ASA404) in Solid Tumors(DMXAA) | completed | Phase 1 | 63 | Cancer Research UKOTHER | 0 | Mar 18, 2009 | clinicaltrials |
| NCT00827203 | A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors | suspended | Phase 1 | 30 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 9, 2009 | clinicaltrials |
| NCT00116896 | Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors | completed | Phase 1 | 25 | OSI PharmaceuticalsINDUSTRY | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00712504 | Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer | completed | Phase 1 | 49 | PfizerINDUSTRY | 1 | Nov 11, 2008 | clinicaltrials |
| NCT00003705 | BMS-184476 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | San Antonio Cancer InstituteOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00005611 | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Jul 24, 2008 | clinicaltrials |
| NCT00043095 | BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00100958 | Indole-3-Carbinol in Preventing Cancer in Healthy Participants | completed | Phase 1 | — | University of KansasOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00460278 | Study of XL418 in Adults With Solid Tumors | suspended | Phase 1 | 63 | ExelixisINDUSTRY | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00657176 | An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 36 | Korea Otsuka Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00591682 | MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors | suspended | Phase 1 | 27 | Metastatix, Inc.INDUSTRY | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00394446 | Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors | completed | Phase 1 | 48 | Myrexis Inc.INDUSTRY | 1 | Feb 13, 2008 | clinicaltrials |
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | terminated | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00100347 | Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors | terminated | Phase 1 | 45 | PRAECIS Pharmaceuticals Inc.INDUSTRY | 1 | Jul 25, 2007 | clinicaltrials |
| NCT00262327 | Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Jun 20, 2006 | clinicaltrials |
| NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | terminated | Phase 1 | 24 | Wellstat TherapeuticsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Mar 16, 2010source: clinicaltrials